Weinreb Jeffrey C
Yale School of Medicine, New Haven, Connecticut 06520-8042, USA.
J Am Coll Radiol. 2008 Jan;5(1):53-6. doi: 10.1016/j.jacr.2007.08.012.
To limit patients who may be at risk for nephrogenic systemic fibrosis from exposure to gadolinium-based magnetic resonance contrast agents, new policies and procedures have been implemented at Yale-New Haven Hospital. These changes include screening patients for low estimated glomerular filtration rates and risk factors for chronic kidney disease, giving increased attention to the types and doses of contrast agent administered, agreement on alternative imaging algorithms, and education at all levels of the medical community. The rationale for these changes is discussed.
为了限制可能有发生肾源性系统性纤维化风险的患者接触钆基磁共振造影剂，耶鲁-纽黑文医院已实施了新的政策和程序。这些变化包括筛查患者的低估计肾小球滤过率和慢性肾病风险因素，更加关注所使用造影剂的类型和剂量，就替代成像算法达成共识，以及在整个医学界开展教育。本文讨论了这些变化的基本原理。
